Tectonic Therapeutic (TECX) Income from Non-Controlling Interests (2023 - 2026)
Tectonic Therapeutic's (TECX) quarterly Income from Non-Controlling Interests came in at $25.2 million in Q1 2026, up 58.39% year-on-year from $15.9 million in Q1 2025, and up 30.95% on a QoQ basis from $19.2 million in Q4 2025.
Tectonic Therapeutic (TECX) Income from Non-Controlling Interests (2023 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 4 years of Income from Non-Controlling Interests data on file, last reported at $25.2 million in Q1 2026.
- On a quarterly basis, Income from Non-Controlling Interests rose 58.39% year-over-year to $25.2 million in Q1 2026; TTM through Mar 2026 was $83.5 million, a 42.52% increase from a year earlier, with the FY2025 full-year figure at $74.3 million, up 28.09% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at $25.2 million, up from $19.2 million in the prior quarter.
- Over the last five years, Income from Non-Controlling Interests for TECX reached as high as $25.2 million in Q1 2026 and fell as low as $7.9 million in Q4 2023.
- Historically, Income from Non-Controlling Interests has averaged $15.5 million across 4 years, with a median of $15.6 million in 2024.
- Across the five-year window, Income from Non-Controlling Interests jumped 76.38% in 2024 and rose 4.2% in 2025, its largest moves.
- Year by year, Income from Non-Controlling Interests stood at $7.9 million in 2023, then surged by 56.07% to $12.3 million in 2024, then soared by 56.51% to $19.2 million in 2025, then jumped by 30.95% to $25.2 million in 2026.
- Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were $25.2 million in Q1 2026, $19.2 million in Q4 2025, and $19.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tectonic Therapeutic | 595.23 Mn | 595.23 Mn | - | 25.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.20 Mn |
| Dec 31, 2025 | 19.25 Mn |
| Sep 30, 2025 | 19.06 Mn |
| Jun 30, 2025 | 20.04 Mn |
| Mar 31, 2025 | 15.91 Mn |
| Dec 31, 2024 | 12.30 Mn |
| Sep 30, 2024 | 17.73 Mn |
| Jun 30, 2024 | 12.68 Mn |
| Mar 31, 2024 | 15.27 Mn |
| Dec 31, 2023 | 7.88 Mn |
| Sep 30, 2023 | 10.05 Mn |
| Jun 30, 2023 | 10.46 Mn |